Logo for Seagen Inc

Seagen Investor Relations Material

Latest events

Logo for Seagen Inc

Q4 2022

Logo for Seagen

Q3 2023

1 Nov, 2023
Logo for Seagen

Q2 2023

2 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Seagen Inc

Access all reports
Segment Data
Access more data
Revenue by
Net product sales
Royalty revenues
Collaboration and license agreement revenues
Expenses by
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer. The company markets LONZA (vinorelbine tartrate) injection, which is used to treat various types of cancer. It also focuses on the development of Seaglass (poly-L-glutamic acid), a compound that is undergoing clinical study for the treatment of chemotherapy-induced nausea and vomiting (CINV). The company was formerly known as Ocean Pharmaceuticals, Inc. and changed its name to Seagen Inc. in August 1995. Seagen Inc. is based in Bothell, Washington.